Description

This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.

Resources

Name	Format	Description	Link
Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/covid-19-regulations/post-authorization-requirements.html
Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/covid-19-reglement/exigences-apres-autorisation.html

Tags

Topics

Categories